APA (7th ed.) Citation

ME, G., GE, G., MM, S., M, W., D, J., C, B., . . . D, N. (2025). Challenges to initiate and complete a 4-month rifapentine-moxifloxacin TB treatment regimen. The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease, 29(7), 318. https://doi.org/10.5588/ijtld.24.0616

Chicago Style (17th ed.) Citation

ME, Galvis, et al. "Challenges to Initiate and Complete a 4-month Rifapentine-moxifloxacin TB Treatment Regimen." The International Journal of Tuberculosis and Lung Disease : The Official Journal of the International Union Against Tuberculosis and Lung Disease 29, no. 7 (2025): 318. https://doi.org/10.5588/ijtld.24.0616.

MLA (9th ed.) Citation

ME, Galvis, et al. "Challenges to Initiate and Complete a 4-month Rifapentine-moxifloxacin TB Treatment Regimen." The International Journal of Tuberculosis and Lung Disease : The Official Journal of the International Union Against Tuberculosis and Lung Disease, vol. 29, no. 7, 2025, p. 318, https://doi.org/10.5588/ijtld.24.0616.